638
Views
55
CrossRef citations to date
0
Altmetric
Original

SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS

Pages 775-826 | Received 26 Mar 2006, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

. (2017) ALSUntangled 40: Ayahuasca. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 627-631.
Read now
Martin R Turner, Federica Agosta, Peter Bede, Varan Govind, Dorothée Lulé & Esther Verstraete. (2012) Neuroimaging in Amyotrophic Lateral Sclerosis. Biomarkers in Medicine 6:3, pages 319-337.
Read now
Ilya D. Ionov. (2007) Survey of ALS‐associated factors potentially promoting Ca2+ overload of motor neurons. Amyotrophic Lateral Sclerosis 8:5, pages 260-265.
Read now
Johanna M. H. Anneser, Ralf J. Jox & Gian Domenico Borasio. (2007) Inappropriate sexual behaviour in a case of ALS and FTD: Successful treatment with sertraline. Amyotrophic Lateral Sclerosis 8:3, pages 189-190.
Read now

Articles from other publishers (51)

Lu Yang, Yanfei Cheng, Yicheng Zhu, Liying Cui & Xiaoguang Li. (2023) The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence. Cellular and Molecular Neurobiology 43:6, pages 2387-2414.
Crossref
Riya Ben Patel, Akhilesh Kumar Bajpai & Kavitha Thirumurugan. (2023) Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis. Journal of Molecular Neuroscience 73:6, pages 375-390.
Crossref
Antony JustinDeepthi MuruganMeghana BasavarajAshwini Prem Kumar. (2023) Are 5HT7 Receptors Possible Target for Multiple Sclerosis?. Research Journal of Pharmacy and Technology, pages 1514-1520.
Crossref
Ana B. Caniceiro, Beatriz Bueschbell, Anke C. Schiedel & Irina S. Moreira. (2022) Class A and C GPCR Dimers in Neurodegenerative Diseases. Current Neuropharmacology 20:11, pages 2081-2141.
Crossref
Pei He, Binjun He, Shu Li, Wen Chai, Wei Rao, Yu Zhu, Wenzhi Chen, Ping Zhang, Xiong Zhang, Haili Pan & Renshi Xu. (2022) Distribution Features and Potential Effects of Serotonin in the Cerebrum of SOD1 G93A Transgenic Mice. eneuro 9:6, pages ENEURO.0001-22.2022.
Crossref
Ruizhuo Li, Mengjuan Deng, Yuhong Lin, Wenjing Gao, Bohao Liu & Huimin Xia. (2022) Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: A Mendelian randomization analysis. Frontiers in Aging Neuroscience 14.
Crossref
Yuma T. Ortiz, Lance R. McMahon & Jenny L. Wilkerson. (2022) Medicinal Cannabis and Central Nervous System Disorders. Frontiers in Pharmacology 13.
Crossref
Elizabeth Minj, Shubham Upadhayay & Sidharth Mehan. (2021) Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS. Neurochemical Research 46:11, pages 2867-2884.
Crossref
Atiah H. Almalki, Ibrahim A. Naguib, Fahad S. Alshehri, Badrah S. Alghamdi, Hashem O. Alsaab, Yusuf S. Althobaiti, Sameer Alshehri & Fatma F. Abdallah. (2021) Application of Three Ecological Assessment Tools in Examining Chromatographic Methods for the Green Analysis of a Mixture of Dopamine, Serotonin, Glutamate and GABA: A Comparative Study. Molecules 26:18, pages 5436.
Crossref
Jennifer A. Fifita, Sandrine Chan Moi Fat, Emily P. McCann, Kelly L. Williams, Natalie A. Twine, Denis C. Bauer, Dominic B. Rowe, Roger Pamphlett, Matthew C. Kiernan, Vanessa X. Tan, Ian P. Blair & Gilles J. Guillemin. (2021) Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis. Frontiers in Immunology 12.
Crossref
Mark A. Masino & Jacob E. Montgomery. 2021. Diagnosis, Management and Modeling of Neurodevelopmental Disorders. Diagnosis, Management and Modeling of Neurodevelopmental Disorders 533 543 .
Alizée Arnoux & Luc Dupuis. 2021. 5-HT2B Receptors. 5-HT2B Receptors 367 386 .
Martin R. Turner & Marco Pagani. 2021. PET and SPECT in Neurology. PET and SPECT in Neurology 759 781 .
Zeynep I. Gunes, Vanessa W. Y. Kan, XiaoQian Ye & Sabine Liebscher. (2020) Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology. Frontiers in Neuroscience 14.
Crossref
Kate L. Osman, Sabrina Kohlberg, Alexis Mok, Ryan Brooks, Lori A. Lind, Katelyn McCormack, Andries Ferreira, Matan Kadosh, Mary K. Fagan, Elizabeth Bearce, Nicole L. Nichols, Joan R. Coates & Teresa E. Lever. (2019) Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery. Dysphagia 35:2, pages 343-359.
Crossref
Elodie Martin, William Cazenave, Anne-Emilie Allain, Daniel Cattaert & Pascal Branchereau. (2020) Implication of 5-HT in the Dysregulation of Chloride Homeostasis in Prenatal Spinal Motoneurons from the G93A Mouse Model of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 21:3, pages 1107.
Crossref
Robert J. Carey. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin 461 467 .
Vanessa X. Tan & Gilles J. Guillemin. (2019) Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 13.
Crossref
Megan M. Haney, Joseph Sinnott, Kate L. Osman, Ian Deninger, Ellyn Andel, Victoria Caywood, Alexis Mok, Brayton Ballenger, Kevin Cummings, Lori Thombs & Teresa E. Lever. (2019) Mice Lacking Brain‐Derived Serotonin Have Altered Swallowing Function. Otolaryngology–Head and Neck Surgery 161:3, pages 468-471.
Crossref
Khalid B. Mirza, Caroline T. Golden, Konstantin Nikolic & Christofer Toumazou. (2019) Closed-Loop Implantable Therapeutic Neuromodulation Systems Based on Neurochemical Monitoring. Frontiers in Neuroscience 13.
Crossref
Aruna Sharma, Mark A. Smith, Dafin Fior Muresanu, Prasanta Kumar Dey & Hari Shanker Sharma. 2019. New Therapeutic Strategies for Brain Edema and Cell Injury. New Therapeutic Strategies for Brain Edema and Cell Injury 1 44 .
Ahsan F. Bairam, Mohammed I. Rasool, Fatemah A. Alherz, Maryam S. Abunnaja, Amal A. El Daibani, Saud A. Gohal, Katsuhisa Kurogi, Yoichi Sakakibara, Masahito Suiko & Ming-Cheh Liu. (2018) Sulfation of catecholamines and serotonin by SULT1A3 allozymes. Biochemical Pharmacology 151, pages 104-113.
Crossref
Yannick Vermeiren, Jana Janssens, Debby Van Dam & Peter P. De Deyn. (2018) Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes. Frontiers in Neuroscience 12.
Crossref
Franck Patin, Philippe Corcia, Patrick Vourc’h, Lydie Nadal-Desbarats, Thomas Baranek, Jean-François Goossens, Sylviane Marouillat, Anne-Frédérique Dessein, Amandine Descat, Blandine Madji Hounoum, Clément Bruno, Samuel Leman, Christian R Andres & Hélène Blasco. (2016) Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism. Molecular Neurobiology 54:7, pages 5361-5374.
Crossref
Jolanta Dorszewska, Jolanta Florczak-Wyspianska, Marta Kowalska, Marcin Stanski, Alicja Kowalewska & Wojciech Kozubski. 2017. Serotonin - A Chemical Messenger Between All Types of Living Cells. Serotonin - A Chemical Messenger Between All Types of Living Cells.
Tatiana Fomina, Sebastian Weichwald, Matthis Synofzik, Jenifer Just, Ludger Schöls, Bernhard Schölkopf & Moritz Grosse-Wentrup. (2017) Absence of EEG correlates of self-referential processing depth in ALS. PLOS ONE 12:6, pages e0180136.
Crossref
Franck Patin, Thomas Baranek, Patrick Vourc'h, Lydie Nadal-Desbarats, Jean-François Goossens, Sylviane Marouillat, Anne-Frédérique Dessein, Amandine Descat, Blandine Madji Hounoum, Clément Bruno, Hervé Watier, Mustafa Si-Tahar, Samuel Leman, Jean-Claude Lecron, Christian R. Andres, Philippe Corcia & Hélène Blasco. (2016) Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism. Neurotherapeutics 13:4, pages 905-917.
Crossref
Jolene Zheng, Mingming Wang, Wenqian Wei, Jeffrey N. Keller, Binita Adhikari, Jason F. King, Michael L. King, Nan Peng & Roger A. Laine. (2016) Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans, a Potential Etiology of Parkinson’s Disease. Frontiers in Nutrition 3.
Crossref
Anna L Stern & Nirinjini Naidoo. (2015) Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. SpringerPlus 4:1.
Crossref
Chrystian J. Alves, Jessica R. Maximino & Gerson Chadi. (2015) Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotrophic Lateral Sclerosis. Frontiers in Cellular Neuroscience 9.
Crossref
Amedeo Pau, Marco Catto, Giovanni Pinna, Simona Frau, Gabriele Murineddu, Battistina Asproni, Maria M. Curzu, Leonardo Pisani, Francesco Leonetti, Maria Isabel Loza, José Brea, Gérard A. Pinna & Angelo Carotti. (2015) Multitarget‐Directed Tricyclic Pyridazinones as G Protein‐Coupled Receptor Ligands and Cholinesterase Inhibitors. ChemMedChem 10:6, pages 1054-1070.
Crossref
Robert J. Carey & Ernest N. Damianopoulos. (2015) Serotonin and conditioning: Focus on Pavlovian psychostimulant drug conditioning. Behavioural Brain Research 282, pages 227-236.
Crossref
Marta Ruiz, Ana Fe Martínez-Vidal, José Manuel Morales, Daniel Monleón & Minerva Giménez y Ribotta. (2014) Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron degeneration. Neuropharmacology 83, pages 137-153.
Crossref
J. E. KoschnitzkyK. A. QuinlanT. J. LukasE. KajtazE. J. KocevarW. F. MayersT. Siddique & C. J. Heckman. (2014) Effect of fluoxetine on disease progression in a mouse model of ALS. Journal of Neurophysiology 111:11, pages 2164-2176.
Crossref
Deepa B. Rao, Peter B. Little & Robert C. Sills. (2013) Subsite Awareness in Neuropathology Evaluation of National Toxicology Program (NTP) Studies. Toxicologic Pathology 42:3, pages 487-509.
Crossref
Nicolas Delestrée, Marin Manuel, Caroline Iglesias, Sherif M. Elbasiouny, C. J. Heckman & Daniel Zytnicki. (2014) Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis. The Journal of Physiology 592:7, pages 1687-1703.
Crossref
Martin R. Turner. 2014. PET and SPECT in Neurology. PET and SPECT in Neurology 639 654 .
Yin?M. Yang, Shailesh?K. Gupta, Kevin?J. Kim, Berit?E. Powers, Antonio Cerqueira, Brian?J. Wainger, Hien?D. Ngo, Kathryn?A. Rosowski, Pamela?A. Schein, Courtney?A. Ackeifi, Anthony?C. Arvanites, Lance?S. Davidow, Clifford?J. Woolf & Lee?L. Rubin. (2013) A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS. Cell Stem Cell 12:6, pages 713-726.
Crossref
José Julio Rodríguez, Harun N. Noristani & Alexei Verkhratsky. (2012) The serotonergic system in ageing and Alzheimer's disease. Progress in Neurobiology 99:1, pages 15-41.
Crossref
Gregory E. Bigford, Nauman S. Chaudhry, Robert W. Keane & Alice M. Holohean. (2012) 5-Hydroxytryptamine 5HT2C Receptors Form a Protein Complex with N-Methyl-d-aspartate GluN2A Subunits and Activate Phosphorylation of Src Protein to Modulate Motoneuronal Depolarization. Journal of Biological Chemistry 287:14, pages 11049-11059.
Crossref
C. F. Meehan, M. Moldovan, S. L. Marklund, K. S. Graffmo, J. B. Nielsen & H. Hultborn. (2010) Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase‐1 mutant mouse in vivo : evidence for increased persistent inward currents . Acta Physiologica 200:4, pages 361-376.
Crossref
Luc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, Philippe Jullien, Lucette Lacomblez, François Salachas, Gaëlle Bruneteau, Pierre-François Pradat, Jean-Philippe Loeffler & Vincent Meininger. (2010) Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE 5:10, pages e13346.
Crossref
M.Z. Kastyak, M. Szczerbowska-Boruchowska, D. Adamek, B. Tomik, M. Lankosz & K.M. Gough. (2010) Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy. Neuroscience 166:4, pages 1119-1128.
Crossref
Farhad Ghoddoussi, Matthew P. Galloway, Amruta Jambekar, Monica Bame, Richard Needleman & William S.A. Brusilow. (2010) Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. Journal of the Neurological Sciences 290:1-2, pages 41-47.
Crossref
Isabella Laura Simone, Rosanna Tortelli, Vito Samarelli, Eustachio D'Errico, Michele Sardaro, Olimpia Difruscolo, Rita Calabrese, Vito De Vito Francesco, Paolo Livrea & Marina de Tommaso. (2010) Laser evoked potentials in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 288:1-2, pages 106-111.
Crossref
Robert J. Carey. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin 325 330 .
C. N. Filer. (2008) Radiolabeling of serotonergic ligands with tritium and iodine-125. Journal of Radioanalytical and Nuclear Chemistry 277:3, pages 707-714.
Crossref
Anna Casanovas, Sara Hernández, Olga Tarabal, Jaume Rosselló & Josep E. Esquerda. (2007) Strong P2X 4 purinergic receptor‐like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis . Journal of Comparative Neurology 506:1, pages 75-92.
Crossref
Shin Yasuda, Ming‐Yih Liu, Masahito Suiko, Yoichi Sakakibara & Ming‐Cheh Liu. (2007) Hydroxylated serotonin and dopamine as substrates and inhibitors for human cytosolic SULT1A3. Journal of Neurochemistry 103:6, pages 2679-2689.
Crossref
Marina Quartu, Maria Pina Serra, Marianna Boi, Maria Teresa Ferretti, Maria Letizia Lai & Marina Del Fiacco. (2007) Tissue distribution of Ret, GFRalpha-1, GFRalpha-2 and GFRalpha-3 receptors in the human brainstem at fetal, neonatal and adult age. Brain Research 1173, pages 36-52.
Crossref
M. R. TurnerE. A. RabinerA. Al-ChalabiC. E. ShawD. J. BrooksP. N. LeighP. M. Andersen. (2007) Cortical 5-HT 1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS . Neurology 68:15, pages 1233-1235.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.